oa CSIR Science Scope - Nanotechnology to improve treatment of diseases



Infectious diseases such as tuberculosis (TB), malaria and HIV/Aids contribute significantly to the high mortality rate in Africa. While research into and development of new TB drugs, in particular, have languished under a perceived lack of need in the developed world, the CSIR has brought together a consortium of universities and research institutions to address this crucial issue. Led by Dr Hulda Swai, a senior researcher in polymers, ceramics and composites with CSIR Materials Science and Manufacturing, the consortium is developing a nanoparticle-based drug delivery system to improve treatment of infectious diseases.


Article metrics loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error